Sale!

KCNMA1 Gene Generalized Epilepsy and Paroxysmal Dyskinesia Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “KCNMA1 Gene Generalized Epilepsy and Paroxysmal Dyskinesia Genetic Test” is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the KCNMA1 gene. Mutations in this gene are known to be associated with a range of neurological conditions, including generalized epilepsy and paroxysmal dyskinesia. These disorders are characterized by recurrent seizures and involuntary movements, respectively, which can significantly impact an individual’s quality of life.

This genetic test involves analyzing the patient’s DNA to detect abnormalities in the KCNMA1 gene, providing crucial information for accurate diagnosis and tailored treatment planning. It is particularly beneficial for individuals who exhibit symptoms of these conditions or have a family history of related neurological disorders.

The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to perform the analysis. Conducted at DNA Labs UAE, a leading facility in genetic testing, patients can expect high-quality service and reliable results. This test represents a significant step forward in the personalized treatment of neurological conditions, offering hope to many individuals and families affected by these challenging disorders.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test

At DNA Labs UAE, we offer the KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test at a cost of AED 4400.0. This test is used to diagnose and analyze the KCNMA1 gene for mutations and variants that may contribute to the development of generalized epilepsy and paroxysmal dyskinesia (GEPD).

Test Components

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

The report for the KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test will be delivered within 3 to 4 weeks.

Method

The test is conducted using NGS (Next-Generation Sequencing) technology.

Test Type

The KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test falls under the category of Neurological Disorders.

Doctor

This test is recommended by Neurologists.

Test Department

The KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test is conducted in our Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is undergoing the KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia NGS Genetic DNA Test. A Genetic Counselling session is also recommended to draw a pedigree chart of family members affected with KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia.

Test Details

The KCNMA1 gene is associated with a rare genetic disorder known as generalized epilepsy and paroxysmal dyskinesia (GEPD). Individuals with GEPD experience recurrent episodes of seizures and involuntary movements, including dystonia, chorea, and myoclonus.

NGS genetic testing is used to analyze the KCNMA1 gene for mutations and variants that may contribute to the development of GEPD. This type of testing can help diagnose GEPD and guide treatment decisions. However, it is important to note that genetic testing is not always necessary or appropriate for all individuals with GEPD. A healthcare provider, particularly a Neurologist, can help determine if genetic testing is suitable based on the patient’s medical history, symptoms, and other factors.

Test Name KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia
Test Details

The KCNMA1 gene is associated with a rare genetic disorder known as generalized epilepsy and paroxysmal dyskinesia (GEPD). GEPD is characterized by recurrent episodes of seizures and involuntary movements, including dystonia, chorea, and myoclonus.

NGS (Next-Generation Sequencing) genetic testing can be used to analyze the KCNMA1 gene for mutations and variants that may contribute to the development of GEPD. This type of testing can help diagnose GEPD and guide treatment decisions.

However, it is important to note that genetic testing is not always necessary or appropriate for all individuals with GEPD. A healthcare provider can help determine if genetic testing is appropriate for a particular patient based on their medical history, symptoms, and other factors.